BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 238 filers reported holding BLUEBIRD BIO INC in Q1 2021. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,543 | -92.3% | 10,376 | +9.2% | 0.00% | -100.0% |
| Q4 2020 | $411,000 | -46.1% | 9,501 | -32.8% | 0.00% | -50.0% |
| Q3 2020 | $763,000 | +8.5% | 14,144 | +22.9% | 0.00% | 0.0% |
| Q2 2020 | $703,000 | +78.4% | 11,511 | +33.0% | 0.00% | +100.0% |
| Q1 2020 | $394,000 | -36.9% | 8,655 | +21.3% | 0.00% | 0.0% |
| Q4 2019 | $624,000 | +0.5% | 7,137 | +4.5% | 0.00% | -50.0% |
| Q3 2019 | $621,000 | -32.6% | 6,829 | -5.2% | 0.00% | 0.0% |
| Q2 2019 | $922,000 | -35.5% | 7,207 | -20.6% | 0.00% | -50.0% |
| Q1 2019 | $1,429,000 | +138.2% | 9,080 | +48.1% | 0.00% | +100.0% |
| Q4 2018 | $600,000 | +68.1% | 6,131 | +152.1% | 0.00% | +100.0% |
| Q3 2018 | $357,000 | -8.7% | 2,432 | -14.5% | 0.00% | 0.0% |
| Q3 2017 | $391,000 | – | 2,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |